SCHEMBL6539755

SCHEMBL6539755

CC1(C)OC[C@H](Cc2ccc(NC(=O)Nc3ccccc3)cc2)N1C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.44
RAB9A P51151 7/20 0.44
TP53 P04637 4/20 0.44
POLB P06746 2/20 0.44
KMT2A Q03164 2/20 0.43
TAAR1 Q96RJ0 2/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
MEN1 O00255 1/20 0.43
HPGD P15428 1/20 0.43
PTPN1 P18031 1/20 0.43
MAPK1 P28482 2/20 0.42
MAPT P10636 1/20 0.42
HCRTR1 O43613 1/20 0.41
HCRTR2 O43614 1/20 0.41
MAOB P27338 1/20 0.40
LMNA P02545 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
HTR1A P08908 1/20 0.40
DRD2 P14416 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6539853 1.00 NPC1 (0.44) NPC1RAB9ATP53POLBKMT2A
SCHEMBL7691950 0.91 MAPT (0.42) NPC1RAB9ATP53POLBKMT2A
SCHEMBL6538746 0.89 PPARA (0.46) NPC1RAB9APOLBKMT2ASMN1; SMN2
SCHEMBL6541438 0.81 CAPN1 (0.38) KMT2ASMN1; SMN2HPGDMAPTCA2
SCHEMBL6541442 0.81 CAPN1 (0.38) KMT2ASMN1; SMN2HPGDMAPTCA2
SCHEMBL6541124 0.81 NAMPT (0.42) CA1CA2
SCHEMBL6541230 0.81 ALDH1A1 (0.39) SMN1; SMN2HPGDMAPK1MAPTTSHR
SCHEMBL6541226 0.81 ALDH1A1 (0.39) SMN1; SMN2HPGDMAPK1MAPTTSHR
SCHEMBL6541119 0.81 NAMPT (0.42) CA1CA2
SCHEMBL6539634 0.80 MAPT (0.38) KMT2ASMN1; SMN2MEN1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6826033-B2 BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
US-20040037022-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-02-26 US disclosed